Thrivent Financial for Lutherans

Thrivent Financial for Lutherans’s Rocket Pharmaceuticals RCKT Stock Holding History

Thrivent Financial for Lutherans’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35,817	Closed	-$117K	–	2633
2025 Q3	$117K	Sell	35,817 -17,629	-33%	-$55.5K	﹤0.01%	2346
2025 Q2	$131K	Hold	53,446	–	–	﹤0.01%	2412
2025 Q1	$356K	Hold	53,446	–	–	﹤0.01%	2184
2024 Q4	$671K	Sell	53,446 -21,731	-29%	-$327K	﹤0.01%	2129
2024 Q3	$1.39M	Hold	75,177	–	–	﹤0.01%	1698
2024 Q2	$1.62M	Sell	75,177 -3,210	-4%	-$73.7K	﹤0.01%	1532
2024 Q1	$2.11M	Hold	78,387	–	–	﹤0.01%	1370
2023 Q4	$2.35M	Sell	78,387 -3,827	-5%	-$84.5K	0.01%	1279
2023 Q3	$1.68M	Buy	+82,214	New	+$1.49M	﹤0.01%	1410

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Citigroup New York $157B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return